抗利尿激素分泌失调综合征

Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med. 2006;119(suppl 1):S36-S42.

• 摘要

Lien YH, Shapiro JI. Hyponatremia: clinical diagnosis and management. Am J Med. 2007;120:653-658.

• 摘要

Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064-2072.

• 摘要

Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int. 2006;69:2124-2130.

• 摘要

1.  Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med. 2006;119(suppl 1):S36-S42.

• 摘要

2.  Feldman BJ, Rosenthal SM, Vargas GA, et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005;352:1884-1890.

• 全文
• 摘要

3.  Anderson RJ, Chung H-M, Kluge R, et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102:164-168.

• 摘要

4.  Lien YH, Shapiro JI. Hyponatremia: clinical diagnosis and management. Am J Med. 2007;120:653-658.

• 摘要

5.  Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119(suppl 1): S30-S35.

• 摘要

6.  Ellis SJ. Severe hyponatremia: complications and treatment. QJM. 1995;88:905-909.

• 摘要

7.  Robertson GL. Antidiuretic hormone: normal and disordered function. Endocrinol Metab Clin North Am. 2001;30:671-694.

• 摘要

8.  Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43:1410-1413.

• 摘要

9.  Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064-2072.

• 摘要

10.  Chung HM, Kluge R, Schrier RW, et al. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83:905-908.

• 摘要

11.  Diringer MN, Zazulia AR. Hyponatremia in neurologic patients: consequences and approaches to treatment. Neurologist. 2006;12:117-126.

• 摘要

12.  Singh S, Bohn D, Carlotti A, et al. Cerebral salt wasting: truth, fallacies, theories, and challenges. Crit Care Med. 2002;30:2575-2579.

• 摘要

13.  Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581-1589.

• 摘要

14.  Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci. 2003;326:25-30.

• 摘要

15.  Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int. 2006;69:2124-2130.

• 摘要

16.  Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;335:2099-2112.

• 全文
• 摘要

17.  Dixon MB, Lien YH. Tolvaptan and its potential in the treatment of hyponatremia. Ther Clin Risk Manag. 2008;4:1149-1155.

• 摘要

18.  Berl T, Quittnat-Pelletier F, Verbalis JG, et al; SALTWATER Investigators. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol. 2010;21:705-712.

• 摘要

19.  Cawley MJ. Hyponatremia: current treatment strategies and the role of vasopressin antagonists. Ann Pharmacother. 2007;41:840-850.

• 摘要

20.  Nemerovski C, Hutchinson DJ. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review. Clin Ther. 2010;32:1015-1032.

• 摘要

21.  Decaux G, Waterlot Y, Genette F, et al. Inappropriate secretion of antidiuretic hormone treated with frusemide. Br Med J (Clin Res Ed). 1982;285:89-90.

• 全文
• 摘要

22.  Kokko JP. Symptomatic hyponatremia with hypoxia is a medical emergency. Kidney Int. 2006;69:1291-1293.

• 摘要

23.  Gross P, Reimann D, Henschkowski J, et al. Treatment of severe hyponatremia: conventional and novel aspects. J Am Soc Nephrol. 2001;12(suppl 1):S10-S14.

• 全文
• 摘要

24.  Ayus JC, Caputo D, Bazerque F, et al. Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series. Am J Kidney Dis. 2015;65:435-442.

• 全文
• 摘要